Glycomine
Biotechnology company developing substrate replacement therapies for congenital disorders of glycosylation (CDG), rare genetic diseases affecting sugar metabolism.
Website
https://www.glycomine.comLocation
San Carlos, California, USA
Founded
2012
Investors
1
Categories
rare-disease, therapeutics, biotech, glycosylation
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |